Search
for
Sort by
Research 601–630 of 1000+
- New potential antiscarring approaches
- Treatment of scleromyxoedema with hydroxychloroquine
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Hair loss
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Symptom management in inflammatory bowel disease
- Dermatological problems following spinal cord injury in Korean patients
- Hair Growth Promoting Effect of 4HGF Encapsulated with PGA Nanoparticles (PGA-4HGF) by β-Catenin Activation and Its Related Cell Cycle Molecules
- The role of photobiomodulation when associated with microneedling in female pattern hair loss
- Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Nutritional Clinical Studies in Dermatology
- Hair diameter in systemic lupus erythematosus
- Endocrine disorders and hormonal therapy for adolescent acne
- Recent therapeutic developments for acne
- Superficial Squamous Cell Carcinomas and Extensive Actinic Keratoses of the Scalp Treated with Radiation Therapy
- Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Ophthalmic manifestations of Demodex spp. infection – what should a dermatologist know?
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Dermoscopy: distinguishing malignant tumors from benign
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- A man with changes on nose
- Tacrolimus in Dermatology
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Cutaneous Reactions to Drugs
- Dermatopathology of Common Hair Problems